A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The world-first treatment, currently being developed by University of Queensland researchers, has received $344,000 in funding from the National Foundation for Medical Research and Innovation to help advance the cream through pre-clinical development. Associate Professor James Wells, from UQ’s Frazer Institute, said the cream contained a novel drug that prevented the formation of ...